文献速递流行病学与生物统计

随机效应荟萃分析中的临床异质性:研究间边界估计问题

Clinical heterogeneity in random-effect meta-analysis: Between-study boundary estimate problem.
PubMed 文献 · Stat Med · 2019-07-08

随机效应荟萃分析中,标准方法如(限制性)最大似然常产生研究间方差参数的零或近零估计,导致退化为固定效应模型并忽略临床异质性。作者提出调整最大似然法和敏感性分析框架以解决边界估计问题,并在24项人血白蛋白随机对照试验的荟萃分析中示例。数值评估显示新方法无边界估计且合成结果与标准方法相似,尤其研究数少时。

要点

  • 标准随机效应模型常低估研究间方差,退化为固定效应模型。
  • 调整最大似然法可避免边界估计,小样本时引入偏倚但渐近为零。
  • 新方法提供敏感性分析框架以检查边界估计的发生。

核心结论

  • 调整最大似然法可解决随机效应荟萃分析中研究间方差参数的边界估计问题,避免退化为固定效应模型。

研究设计与样本

  • 方法学研究,提出调整最大似然估计和敏感性分析框架,并以24项人血白蛋白随机对照试验的荟萃分析为例说明。

主要发现

  • 标准(限制性)最大似然法常产生研究间方差参数的零或近零估计。
  • 调整最大似然法在小研究数K时引入偏倚但渐近趋于零,大K时估计一致。
  • 限制性最大似然法与调整法在均方误差准则下等价至O(K^-1)阶。
  • 数值评估显示调整法无边界估计,合成结果与标准最大似然法相似。

临床怎么用

  • 在随机效应荟萃分析中可采用调整最大似然法避免边界估计,并用敏感性分析框架检查边界估计的发生。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Random-effect meta-analysis is commonly applied to estimate overall effects with unexplained heterogeneity across studies. However, standard methods, including (restricted) maximum likelihood (ML or REML), frequently produce (near) zero estimates for between-study variance parameters. Consequently, these methods are reduced to simple and unrealistic fixed-effect models, resulting in an ignorance of the substantial clinical heterogeneity and sometimes leading to incorrect conclusions. To solve the boundary estimate problem, we propose (1) an adjusted maximum likelihood method for the between-study variance that maximizes a likelihood defined as a product of a standard likelihood and a Gaussian class of adjustment factor and (2) a framework using sensitivity analysis by developing a new criterion to check for the occurrence of the boundary estimate. Although the adjustment introduces bias to the overall effects to ensure strictly positive estimates of the between-study variance when the number of studies K is small, the bias asymptotically approaches zero, resulting in the same estimates derived from the REML method. Moreover, the adjusted maximum likelihood estimator of the between-study variance is consistent for large K, and interestingly, the REML method and our method are equivalent in terms of mean squared error criterion, up to O(K-1 ). We illustrate our approach with a motivating example to examine the controversial result of a meta-analysis for 24 randomized controlled trials of human albumin. Numerical evaluations show that our approach produces no boundary estimates but similar synthesized results with the standard maximum likelihood methods as those produced by conventional methods, especially with a small number of studies.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Yoneoka D, Henmi M. Clinical heterogeneity in random-effect meta-analysis: Between-study boundary estimate problem. Stat Med. 2019. PMID: 31286537. doi:10.1002/sim.8289

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。